The Pulmonary Embolism Response Team (PERT) Consortium was developed after the initial efforts of a team of physicians at Massachusetts General Hospital.
The PERT Consortium® intends to guide and influence pulmonary embolism (PE) care and research in institutions across the U.S. and will be the driving force behind increased survival rates and the future of PE treatment.
It is the intention of the Consortium to increase awareness of treatment options available to patients with PE, to reduce its incidence worldwide, to improve health outcomes, and to positively influence the impact of this terrible disease.
The National PERT Consortium® is a national alliance of like-minded Pulmonary Embolism Response Teams dedicated to improving care and outcomes for patients with PE.
The collaborative work of the National PERT Consortium® will reduce incidence of PE, improve treatment algorithms, save lives, and reduce the burden of this disease in our patients, our communities, and society overall.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Boston, Us
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://pertconsortium.org/
- Keywords
- to this high-impact audience..
- HQ
- Boston
The Pert Consortium® Questions
The Pert Consortium®'s website is https://pertconsortium.org/
The Pert Consortium®'s LinkedIn profile is https://www.linkedin.com/company/pertconsortium
The Pert Consortium® has
10 employees.
View email and phone details for 10
employees at The Pert Consortium®.
The Pert Consortium®'s industry is
Hospitals and Health Care
The Pert Consortium®'s top competitors are
Recor Medical,
Penumbra, Inc.,
Thrombolex, Inc.,
Inari Medical,
National Blood Clot Alliance,
E2 - Endovascular Engineering,
Boston Scientific,
International Society On Thrombosis And Haemostasis (Isth),
Shockwave Medical,
Ministry Of National Guard Health Affairs (Mngha).
The Pert Consortium®'s categories are Hospitals and Health Care
The Pert Consortium®'s founding year is 2015
